Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase NA 1

Status

Unknown 4Completed 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 15Breast 14Gastrointestinal 13Head & Neck 6Endocrine 6Thoracic 5Genitourinary 5Tumor-Agnostic 3Other 2Sarcoma 1Other solid neoplasm 1Other neoplasm 1

Conditions

Pituitary Neoplasms 3Pheochromocytoma 2Pituitary Diseases 1Non-functioning Pituitary Adenoma 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Dexmedetomidine × Endocrine × Clear all
NCT06037135 2023-10-06

Dexmedetomidine Infusion During Laparoscopic Adrenalectomy

Yonsei University

Phase NA Completed
40 enrolled
Endocrine

Pheochromocytoma

NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

NCT05005715 2021-08-13

Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery

Seoul National University Hospital

Phase 2 Unknown
64 enrolled
Endocrine

Non-functioning Pituitary Adenoma

NCT04785222 2021-03-05

Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor

Chiang Mai University

Phase 4 Unknown
63 enrolled
Endocrine

Pituitary Neoplasms

NCT03132259 2017-05-30

Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach

Mahidol University

Phase 4 Unknown
124 enrolled
Endocrine

Pituitary Neoplasms

NCT02549768 2016-10-12

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Pontificia Universidad Catolica de Chile

Phase 4 Unknown
40 enrolled
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡